Loïc Le Guennec

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3)

Jean Reignier, Gaëtan Plantefève, Jean‐Paul Mira et al. · The Lancet Respiratory Medicine · 2023 · 219 citations · Full text

Nutrition, Standard Calorie, Parallel-group Trial +6

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

Medicine, Surgery, Clinical Trials +1

COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings

Cécile Delorme, Olivier Paccoud, Aurélie Kas et al. · European Journal of Neurology · 2020 · 173 citations · Full text

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

Aurélie Kas, M. Soret, Nadya Pyatigoskaya et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 168 citations · Full text